Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

Overview of attention for article published in Journal of Nanobiotechnology, September 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 2,674 followers.

RT @lumosa_tx: Combining a #nanoparticle-mediated #immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy…

23 Sep 2022

Reply Repost Favourite

RT @JNanobiotech: New online: 'Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treat…

22 Sep 2022

Reply Repost Favourite

RT @JNanobiotech: New online: 'Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treat…

22 Sep 2022

Reply Repost Favourite

New online: 'Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer' James W. Welsh & colleagues I @MDAndersonNews Read more👇 https://t.co/g7df8ro2xG

21 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.